Product Images Menactra
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Menactra NDC 49281-589 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 0.5 mL Vial Label - menactra 01
This is a description of Menactra® vaccine, a meningococcal conjugate vaccine manufactured by Sanofi Pasteur Inc. The vaccine provides protection against meningococcal infections caused by groups A, C, Y, and W-135. The NDC code for the vaccine is 49281-589-58, and it is available in a single-dose form. The vaccine contains Diphtheria Toxoid Polysaccharide along with the meningococcal conjugate vaccine. The text appears to be missing some vital information, such as dosage and administration details.*
PRINCIPAL DISPLAY PANEL - 5 Vial Package - menactra 02
This is a description of a vaccine called Menactra, which is used to protect against Meningococcal disease caused by bacteria groups A, C, Y, and W-135. The vaccine is administered intramuscularly with a dosage of 0.5 mL per dose containing 4 meg of each polysaccharide per serogroup. The vaccine should not be frozen and should be stored at 2°C to 8°C. The vaccine is manufactured by Sanofi Pasteur Inc. and has no preservatives. Menactra is intended for people aged 9 months through 55 years.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.